Connection

Peter Jüni to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications Peter Jüni has written about Drug Therapy, Combination.
Peter Jüni
Connection Strength
0.051
Drug Therapy, Combination
  1. Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial. Eur Heart J. 2019 08 14; 40(31):2595-2604.
    View in: PubMed
    Score: 0.018
  2. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet. 2018 09 15; 392(10151):940-949.
    View in: PubMed
    Score: 0.017
  3. [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.] Kardiol Pol. 2017; 75(12):1217-1299.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.